Physician profile
Eric S Hogan
NPI 1669769451
$6,491.16
in general payments reported to CMS, 2019-2025
57 companies · $850 in 2025
The $850 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $868 · 2021: $940 · 2022: $1,152 · 2023: $1,106 · 2024: $768 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,723.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,139.55 | 2021-2025 | |
| Lilly USA, LLC | $582.20 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $462.30 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $411.91 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Astrazeneca Pharmaceuticals LP | $401.89 | 2019-2025 | Farxiga |
| Astellas Pharma US INC | $321.67 | 2019-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $291.32 | 2019-2023 | Xarelto |
| Pfizer INC. | $271.34 | 2019-2025 | |
| Amgen INC. | $232.55 | 2019-2023 | Prolia, Evenity |
| Abbott Laboratories | $207.57 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amarin Pharma, INC. | $161.15 | 2020-2021 | |
| Novo Nordisk INC | $156.58 | 2019-2025 | Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $134.66 | 2022 | |
| Allergan, INC. | $117.60 | 2020 | |
| Merck Sharp & Dohme LLC | $109.58 | 2020-2025 | Vaxelis, Gardasil 9, Capvaxive |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.